U S G r a n t s . c o m
June 22, 2024, 8:52 am UTC

Tri City Research Center 2305232075 | Government Grant Application

Tri City Research Center | Application Preview

  • General Information

    Business Registration Number: 2305232075

    Location: Grand Island, NE, United States

    Length of Operation: 1-5

    Number of Employees: 1-10 Employees

    Annual Gross Income: Less than $100k

    Annual Gross Expense: Less than $100k

    Open to Loans: NO

  • Funding Usage

    Recruitment of participants, compensation for participants, salary for staff, infrastructure / equipment, and compensation for investigators.

  • Business Plan

    Our five-year objective at TriCity Research Center (TCRC) is to solidify our position as a premier institution for clinical trials specifically focused on pain medicine and related conditions. To ensure sustainable growth over the next five years, TriCity Research Center (TCRC) plans to significantly enhance its research capabilities and infrastructure. This includes investing in advanced biomedical equipment and upgrading facilities to support a broader range of clinical trials. Moreover, TCRC will adopt cutting-edge data analysis and trial management software to increase efficiency and accuracy in research processes. By expanding our technological and infrastructural base, we aim to attract more complex and high-value studies from both existing and new industry partners, thereby diversifying our research portfolio and revenue streams. Grant monies will also be used to conduct new research studies that will be of immense value to the industry in terms of the data and findings resulting from it. The company will be established as a prominent research organization capable of conducting advanced trials that will lead to testing of new therapeutic agents and determining their efficacy and safety. Such prominence will attract larger studies which will bring in tax revenue to the state. Investors should consider investing in TriCity Research Center (TCRC) because of our strategic and ambitious plan to significantly enhance our research capabilities and infrastructure over the next five years. By investing in advanced biomedical equipment and upgrading facilities, alongside adopting cutting-edge data analysis and trial management software, TCRC is poised to expand its technological and infrastructural base. This will not only increase the efficiency and accuracy of our research processes but also position us to attract more complex and high-value studies from a diverse range of industry partners. Our commitment to expanding our research portfolio and diversifying our revenue streams through these advancements signals a robust growth trajectory and presents a lucrative opportunity for investors looking to capitalize on the burgeoning medical research sector. Furthermore, our strategy to leverage grant monies for conducting new research studies underscores our dedication to contributing valuable data and findings to the medical industry. TCRC's ambition to establish itself as a prominent research organization capable of conducting advanced trials is not just about enhancing our standing in the research community; it's about driving innovation in testing new therapeutic agents and determining their efficacy and safety. This approach not only promises substantial financial returns for our investors through larger and more prestigious studies but also positions TCRC as a critical contributor to medical advancements and public health. Investing in TCRC means being part of an organization that not only aims for financial success but also endeavors to bring about meaningful change in healthcare, making it an ideal choice for investors committed to impactful investment.

  • Self Identified Competition

    TriCity Research Center (TCRC) faces state-wide competition mainly from three clinical research organizations at. 1. Meridian Clinical Research: With a dedicated research center headquartered in Omaha, Nebraska, Meridian conducts Phase 1-4 studies across North America. Specializing in high-volume vaccine trials, Meridian partners with sponsors and contract research organizations (CROs) worldwide, offering a broad range of therapeutic area expertise. 2. University of Nebraska Medical Center (UNMC): While primarily an academic institution, UNMC engages in a wide array of clinical trials and research projects. Its Clinical Trials Database and active involvement in healthcare research make it a significant player in Nebraska's clinical research landscape. 3. Velocity Clinical Research: Operating multiple locations within Nebraska, including in Lincoln, Omaha, Grand Island, Hastings, and Norfolk, Velocity Clinical Research presents a robust network of research sites. Their experienced investigators and well-trained research staff, coupled with geographic dispersion, enable access to critical subpopulations and ensure world-class quality in trial execution. These organizations represent TCRC's primary competition, each with its strengths and strategic focuses, contributing to a dynamic and competitive clinical research environment in Nebraska. TriCity Research Center (TCRC) distinguishes itself from competitors in Nebraska's clinical research landscape through its unique combination of flexibility, specialization, and geographic focus. Unlike large organizations such as Meridian Clinical Research and Velocity Clinical Research, which might not offer the same level of personalized service and attention to detail, TCRC prides itself on closely collaborating with sponsors to tailor research protocols to meet specific trial needs. Our specialization in pain management trials, led by dedicated specialists, sets us apart in a niche area where others, including academic centers like the University of Nebraska Medical Center (UNMC), may lack the focused expertise or flexibility to conduct such specialized studies. While UNMC, being an academic institution, contributes significantly to the medical research field, its scope and the types of trials it can conduct are inherently limited, particularly in areas requiring deep niche expertise like pain management. Additionally, our rural location and access to a specific demographic give us a unique advantage in recruiting participants who are often underrepresented in clinical trials, enhancing the diversity and applicability of our research findings. This strategic combination of specialization, personalized attention, and unique participant access ensures TCRC not only meets but exceeds the capabilities of our competitors in delivering high-quality, impactful clinical research.

  • Contact Applicant

    Subscribe to our Administrator Dashboard to gain full access to this application. Learn More applicant portal membership